Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Nutrient Agar Substituted for Blood in Antibiograms

By LabMedica International staff writers
Posted on 17 Sep 2012
In laboratories in the developed world, blood agar plates are used to test antibiotic sensitivity of bacteria, but in resource poor laboratories, this may not be feasible.

Beta-hemolytic Streptococcus species also grow on Standard Nutrient Agar 1 (StNA1 and it has been suggested this type of nutrient medium could be used for running agar diffusion tests.

Bacteriologists at Globolab eV Laboratory (Assling, Germany) conducted 103 comparative tests to evaluate the growth characteristics of beta-hemolytic Streptococcus spp. More...
on StNA1 compared to Müller–Hinton agar supplemented with 5% sheep blood (B-MH). The specimens were obtained from patients admitted to a cooperating hospital in Germany and 16 beta-hemolytic streptococci strains were obtained.

Bacteria to be tested are streaked uniformly across a culture plate. Paper disks impregnated with eight different antibiotics (Oxoid; Wesel, Germany) to be tested are placed on the surface of the gelatinous agar. During incubation of the agar plate, the antibiotics diffuse from the disks into the surrounding agar. An effective agent will inhibit bacterial growth, and the size of such a zone of inhibition (ZoI) around the disk is measured. The relative effectiveness of a compound is determined by comparing the diameter of the ZoI with values in standard tables.

The authors found that found in 99 out of 103 (96.12%) of all cases that the absolute values of ZoI differences were smaller than or equal to 3 mm, and 92 out of 103 (89.32%) were smaller than or equal to 2 mm. The Standard Nutrient Agar 1 (StNA1) is marketed by Carl Roth GmbH (Karlsruhe, Germany) can be used for culturing Enterobacteriaceae, Pseudomonas spp., Staphylococcus spp., and Streptococcus spp. The B-MH used in the study was obtained from bioMérieux (Marcy l'Etoile, France).

The authors concluded that although blood agar is always the better choice for several reasons, the reading of the ZoI is often easier on StNA1 than on B-MH. This is because StNA1 is more transparent and, therefore, the edges between bacterial growth and the inhibition zone can be discerned more easily. In such places where no blood agar is available for conducting antibiograms, StNA1 is an appropriate substitute for blood-supplemented Müller–Hinton agar. The study was published on August 29, 2012, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:

Globolab e.V. Laboratory
Oxoid
Carl Roth GmbH




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.